Las Vegas, NV -- (SBWIRE) -- 10/17/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Arch Coal Inc (NYSE:ACI), DryShips Inc. (NASDAQ:DRYS), Keryx Biopharmaceuticals (NASDAQ:KERX), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA).
Arch Coal Inc (NYSE:ACI) opened its shares at the price of $4.04for the day. Its closing price was $3.91 after losing -5.10% for the day. The company traded with the total volume of 13.94 million shares, while its average trading volume remained 8.73 million shares. The beta of ACI stands at1.72.
Has ACI Found The Bottom and Ready To Move Up? Find Out Here
Arch Coal, Inc. (Arch) is the coal producer. The Company sells substantially all of its coal to power plants, steel mills and industrial facilities.
DryShips Inc. (NASDAQ:DRYS) percentage change surged2.40 % to close at $3.46 with the total traded volume of 10.15 million shares, less than average volume of 20.51 million. The 52 week range of the stock remained $1.46- $4.00, while its day lowest price was $3.35 and it hit its day highest price at $3.48.
For How Long DRYS will fight for Profitability? Read This Trend Analysis report
DryShips Inc. (DryShips) is a holding company engaged in the ocean transportation services of drybulk cargoes and crude oil worldwide through the ownership and operation of drybulk carrier vessels and oil tankers and offshore drilling services through the ownership and operation of ultra-deepwater drilling units.
Keryx Biopharmaceuticals (NASDAQ:KERX) remained among the day advancers and traded with volume of 9.50 million shares in the last session, as compared to average volume of 2.13 million shares. Then 52 week range of the stock remained $2.23 - $10.92, while its day lowest price was $8.87 and it hit its day highest price at $10.58. KERX’s total market capitalization is $858.24 billion, along with 81.82 million shares outstanding.
Why Should Investors Buy KERX After The Recent Gain? Just Go Here and Find Out
Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) started its trading session with the price of $4.01 and closed at $4.04 by scoring 0.50%. ARIA’s stocks traded with total volume of 9.08 million shares, while the average trading volume remained 10.86 million shares. The beta of ARIA stands at 1.17. Day range of the stock was $4.01 -$4.18.
Will ARIA Continue To Move Higher? Find Out Here
ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients.
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)